Tanox

2 clinical trials · Sponsor

Record	Firm	Date
Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's Lymphoma (NCT00441818)	Tanox	2006-05-01
TNX-355 With Optimized Background Therapy (OBT) in Treatment-Experienced Subjects With HIV-1 (NCT00089700)	Tanox	2004-03-01

Every clearance here is in the API, with alerts when new ones post.